featured
Gemcitabine + Pazopanib vs Gemcitabine Alone for Persistent or Recurrent Epithelial Ovarian Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Gynecologic Oncology